News Releases

Orexigen Therapeutics to Speak at the Rodman & Renshaw 18th Annual Global Investment Conference

SAN DIEGO, Sept. 7, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Rodman & Renshaw 18th Annual Global Investment Conference. The presentation is scheduled for Monday, September 12, at 9:35 a.m. ET. The conference, sponsored by H.C. Wainwright & Co., will take place in New York City on September 11 - 13, 2016.

To listen to the live webcast or a replay of the discussion, please visit the Investors section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

 

Orexigen Contact:

Media Contact:

McDavid Stilwell

Julie Normart

VP, Corporate Communications and Business Development

BrewLife

(858) 875-8629

(415) 946-1087

mstilwell@orexigen.com

jnormart@brewlife.com

 

SOURCE Orexigen Therapeutics, Inc.